Fact CheckerSign in

NCT05122052Completed

Effect of Gender on Distress and Fatigue in Cancer Patients

Effect of Gender on Distress and Fatigue Over Time in Cancer Patients. A Prospective Longitudinal Study.

Source: ClinicalTrials.gov · Last updated 8 Aug 2025

Brief summary (registry, in English)

Distress in cancer patients has been shown to be higher in females than males, but the behavior of distress during time in longitudinal prospective studies has not been studied, nor is it known if there are differences related to gender during time. These differences may have important therapeutic implications in terms of selective psychological support as cancer progresses during individual trajectories. The aim of the present study is to examine the effect of gender during time on psychological distress and fatigue in cancer patients across a broad range of cancer types. It is hypothesized that women will report higher psychological distress than men at initial visit but a reversed trend will be observed during follow-up as a result of different coping capabilities between men and women. We will also investigate if psychological factors (distress, anxiety and depression) affected antibody response and markers of COVID-19 vaccine activation (C-reactive protein, CRP and D-dimer) after 6 months from initial vaccination. Caregivers will also be interviewed to measure their burden with the Zarit Burden Interview. Patients attending a cancer outpatient clinic are invited to undergo a psychological session immediately before the medical visit. Distress is assessed by the Distress thermometer and fatigue by the ESAS-r scale at the end of the session. Patients will undergo follow-up visits to assess changes during time and possible time by gender interactions.

Status (registry)
Completed
Study type
Observational
Enrollment
500 (actual)
First submitted
4 Nov 2021
Start date
28 Nov 2018
Primary completion date
7 Sept 2024
Lead sponsor
Ente Ospedaliero Ospedali Galliera
NCT number
NCT05122052

What you commit to

  • Study type: Observational
  • Participants enrolled: 500
  • From 28 Nov 2018 to the primary completion date, 7 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None

Who the study is looking for

  • Patients with cancer of any site and stage willing to undergo a psychological interview before the medical visit, including those receiving COVID-19 vaccine.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
E.O. Ospedali Galliera
Coordinator of this site? Confirm its status
GenovaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.